STUDY OF PATIENTS ADHERENCE TO TREATMENT IN METABOLIC SYNDROME, WITH THE NOVEL COMBINATION ANTIHYPERTENSION COMPOUND OF RAMIPRIL AND AMLODIPINE BY THE DATA OF OBSERVATIONAL STUDY GRANAT-1

STUDY OF PATIENTS ADHERENCE TO TREATMENT IN METABOLIC SYNDROME, WITH THE NOVEL COMBINATION ANTIHYPERTENSION COMPOUND OF RAMIPRIL AND AMLODIPINE BY THE DATA OF OBSERVATIONAL STUDY GRANAT-1

Aim.  To  study  some   aspects  of  antihypertension   therapy  (AHT) adherence in patients  with arterial hypertension  (AH) and  metabolic syndrome  (MS) by an  example  of fixed combination  of ramipril and amlodipine,  under  the  framework  of GRANAT-1  trial (Observational Program   for  Pati...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Yu. Martsevich, Yu V. Lukina, E. P. Kutishenko, V. P. Voronina, N. A. Dmitrieva, A. V. Zakharova, O. V. Lerman, A. А. Garganeeva, T. A. Gomova, S. I. Drozdetsky, O. I. Chesnikova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2017-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
arterial hypertension
metabolic syndrome
antihypertension therapy
rational fixed combination
treatment adherence
Online Access:https://cardiovascular.elpub.ru/jour/article/view/565
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://cardiovascular.elpub.ru/jour/article/view/565

Similar Items